Zecotek Reports $622,817 of LFS Scintillation Crystal Sales Revenue for Second Quarter 2016

Medical Device Investing

Zecotek Photonics Inc. (TSXV:ZMS, FWB: W1I, OTCPK: ZMSPF)reported preliminary unaudited revenue for the second quarter ended January 31, 2016.

Zecotek Photonics Inc. (TSXV:ZMS, FWB: W1I, OTCPK: ZMSPF)reported preliminary unaudited revenue for the second quarter ended January 31, 2016. Sales for the second quarter were a record $622,817, a threefold increase from $149,589 recorded in the first quarter of fiscal 2016, and a sevenfold increase compared to the same time period last year. Unaudited revenue for the six months ending January 31, 2016 increased $598,875 to $772,406 from $173,531 for fiscal 2015.
Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc stated:

In the second quarter of 2016, we recorded more revenue than ever before due to sales of our patented LFS scintillation crystals to PET medical scanning device OEMs

Click here to view the full press release. 

The Conversation (0)
×